Anna Laurell
Impact in
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 20
- Genetics 16
- Chronic Lymphocytic Leukemia Research 16
- Co-authors
- Mats Jerkeman (14 shared papers)Christer Sundström (10 shared papers)Arne Kolstad (14 shared papers)Anna Berkenblit (1 shared paper)Jill S. Clancy (1 shared paper)Laurence Moore (1 shared paper)Michael Crump (1 shared paper)Becker Hewes (1 shared paper)
In The Last Decade
Anna Laurell
47 papers receiving 2.0k citations
Anna Laurell's Hit Papers
Peers
Comparison fields: 5 of 78
- Genetics 612
- Pathology and Forensic Medicine 939
- Oncology 688
- Hematology 122
- Surgery 409
Countries citing papers authored by Anna Laurell
This map shows the geographic impact of Anna Laurell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Laurell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Laurell more than expected).
Fields of papers citing papers by Anna Laurell
This network shows the impact of papers produced by Anna Laurell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Laurell. The network helps show where Anna Laurell may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Laurell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma Hit paper breakdown → | 2009 | 505 |
| 2 | 2009 | 167 | |
| 3 | 2011 | 156 | |
| 4 | 2009 | 130 | |
| 5 | 2018 | 104 | |
| 6 | 2014 | 98 | |
| 7 | 2009 | 94 | |
| 8 | 2005 | 91 | |
| 9 | 2016 | 63 | |
| 10 | 2014 | 53 | |
| 11 | 2017 | 48 | |
| 12 | 2011 | 40 | |
| 13 | 2009 | 37 | |
| 14 | 2005 | 32 | |
| 15 | 2005 | 28 | |
| 16 | 2014 | 26 | |
| 17 | 1961 | 26 | |
| 18 | 2006 | 25 | |
| 19 | Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome. | 2005 | 24 |
| 20 | 2015 | 23 |
About Anna Laurell
Anna Laurell is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Pulmonary and Respiratory Medicine and Surgery, having authored 48 papers that have together received 2.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (20 papers), Chronic Lymphocytic Leukemia Research (16 papers), Testicular diseases and treatments (7 papers), Renal cell carcinoma treatment (6 papers), Viral-associated cancers and disorders (6 papers), CNS Lymphoma Diagnosis and Treatment (4 papers), Sarcoma Diagnosis and Treatment (3 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Genetics (612 citations), Pathology and Forensic Medicine (939 citations), Oncology (688 citations), Hematology (122 citations) and Surgery (409 citations). Anna Laurell has collaborated with scholars based in Sweden, Norway and Denmark. Frequent co-authors include Mats Jerkeman, Christer Sundström, Arne Kolstad, Anna Berkenblit, Jill S. Clancy, Laurence Moore, Michael Crump, Becker Hewes, Andrew Strahs and Raoul Herbrecht. Their work appears in journals such as Blood, Journal of Clinical Oncology, Acta Oncologica, Medical Oncology and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.